Jenburkt Pharmaceuticals Q3 Results

  • BSE: 524731
  • NSE: -
  • ISIN: INE354A01013
  • Sector: Biotechnology & Drugs
BSE
1,234.972.55 (6.24%)
Volume3.26 K
Updated: Mon 25 Nov, 2024 | 15:29:56
NSE
This stock is not traded on NSE
Today: 1,162.45
1,260.00
52-Wk: 643.20
1,375.00

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Jenburkt Pharmaceuticals Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 35.6638.29-%34.57-%
    Selling/ General/ Admin Expenses Total 11.5610.89-%10.45-%
    Depreciation/ Amortization 0.630.59-%0.58-%
    Other Operating Expenses Total 9.459.09-%9.03-%
    Total Operating Expense 29.0929.78-%28.17-%
    Operating Income 6.578.51-%6.40-%
    Net Income Before Taxes 7.849.54-%7.76-%
    Net Income 5.407.32-%5.43-%
    Diluted Normalized EPS 12.2516.59-%11.84-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts